Acadia Pharmaceuticals
ACAD
ACAD
187 hedge funds and large institutions have $3.25B invested in Acadia Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 83 increasing their positions, 61 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $4.11B → $3.25B (-$854M)
43% less call options, than puts
Call options by funds: $24.1M | Put options by funds: $42.3M
Holders
187
Holding in Top 10
5
Calls
$24.1M
Puts
$42.3M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$36.5M | |
| 3 | +$27.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$20.4M |
Top Sellers
| 1 | -$47.1M | |
| 2 | -$46.3M | |
| 3 | -$24.5M | |
| 4 |
BJCM
Blue Jay Capital Management
Los Angeles,
California
|
-$12.6M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$9.95M |